Back to top
more

ProShares Ultra Nasdaq Biotechnology: (BIB)

(Delayed Data from NASDAQ) As of May 1, 2024 09:53 AM ET

$51.12 USD

51.118
858

+0.67 (1.32%)

Volume: 858

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

ETF Quote Details

Previous Close 50.45
Open 51.00
Bid 51.01
Ask 51.14
Day Low-High 51.00-51.12
52wk Low-High 40.10-62.45
Volume 858
NAV (month end) 57.53
Premium (+)/Discount (-) (month end)-7.08

Zacks Premium Research for BIB

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 NA
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

High
ETF Research Report

ETF Expense Ratio

Expense Ratio 0.95%
Dividend (Yield) $0.08 (0.16%)
Issuer PROSHARES

Benchmark for BIB

NASDAQ BIOTECHNOLOGY INDEX

The NASDAQ Biotechnology Index is a modified capitalization weighted index that includes securities of The NASDAQ Stock Market listed companies that are classified as either biotechnology or pharmaceutical.

Fund Summary for BIB

PROSHARES ULTRA NASDAQ BIOTECHNOLOGY

The ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the NASDAQ Biotechnology Index.